Federico Nasroulah

Federico Nasroulah, MD, is an accomplished oncology professional with extensive experience in clinical development and leadership roles within the pharmaceutical industry. Currently serving as Executive Director and Global Clinical Lead for Oncology Clinical Development at Daiichi Sankyo, Inc. since January 2024, Federico has previously held significant positions at Bristol Myers Squibb as Clinical Development Lead for Bladder Cancer and Development Program Lead, and at Genentech as Clinical Science Lead and Senior Medical Director for Prostate Cancer. Prior to that, Federico contributed to Eli Lilly and Company as Associate Vice President and held various roles including Senior Medical Director at ImClone Systems and Oncology Regional Medical Advisor for Latin America. Early career experience includes staff physician roles at Sanatorio Güemes and an oncology fellowship at Instituto Alexander Fleming, following an internal medicine residency at Hospital de Clinicas "Jose de San Martin." Federico earned an MD in Medicine from the University of Buenos Aires.